Clinical Trials Logo
  1. Home
  2. Prediabetic State
  3. NCT00561132
  4. Details
NCT00561132 Clinical Trial

Study of Vanadium Supplement in Patients With Impaired Glucose Tolerance

Prediabetic State Clinical Trial

Official title:
Effect of Vanadium on Insulin Sensitivity in Patients With Impaired Glucose Tolerance

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00561132
Other study ID # 2002/252/129
Secondary ID 173/03/13FP-2003
Status Completed
Phase Phase 3
First received November 19, 2007
Last updated November 19, 2007
Start date November 2003
Est. completion date November 2004

Study information
Verified date November 2007
Source Unidad de Investigacion Medica en Epidemiologia Clinica
Contact n/a
Is FDA regulated No
Health authority Mexico: Ministry of Health
Study type Interventional

Clinical Trial Summary

The purpose of this study was to evaluate if the vanadium can improve the insulin sensitivity in patients with impaired glucose tolerance. Secondary purpose of this study was to assess changes on metabolic profile, weight and blood pressure.

Recruitment information / eligibility
Status Completed
Enrollment 14
Est. completion date November 2004
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 40 Years to 50 Years
Eligibility Inclusion Criteria:

- Diagnosis of impaired glucose tolerance

- Body mass index from 25 to 35 kg/m2

- History of type 2 diabetes mellitus in the first branch

Exclusion Criteria:

- Taking medication with known effects on carbohydrate or insulin metabolism

- Thyroid diseases

- Hepatic diseases

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Intervention

Dietary Supplement:
• Vanadyl sulfate
50 mg twice daily orally for a period of 4 weeks
Other:
• Magnesium oxide
Validation of similar appearance and weight to the intervention component orally 1 unit (<50 mg) twice daily for a period of 4 weeks

Locations
Country Name City State
Mexico Unidad de Investigacion Medica en Epidemiologia Clinica, Hospital de Especialidades, UMAE, Centro Medico Nacional de Occidente Guadalajara Jalisco

Sponsors (3)
Lead Sponsor Collaborator
Unidad de Investigacion Medica en Epidemiologia Clinica Doctorado en Farmacologia de la Universidad de Guadalajara, Fondo para el Fomento a la Investigacion Medica

Country where clinical trial is conducted

Mexico, 

Outcome
Type Measure Description Time frame Safety issue
Primary Changes on insulin sensitivity assessed with a euglycemic-hyperinsulinemic clamp technique 4 weeks
Secondary Changes on metabolic profile 4 weeks
Secondary Changes on anthropometrical measures 4 weeks
See also
  Status Clinical Trial Phase
Completed NCT05424107 - A Mediterranean Intervention on Prediabetic Children N/A
Recruiting NCT02681887 - Effect of Melatonin on Cardiometabolic Risk- FULL Phase 3
Completed NCT04088461 - Effect of Linagliptin + Metformin on Patients Who do Not Achieve Normoglucemia With Metformine Phase 4
Recruiting NCT02561377 - Effect of Resistance Training on Metabolic Control and Outcome in Prediabetes (NMR-based Metabonomics) N/A
Completed NCT02551640 - Improving Physical Activity Through a mHealth Intervention in Cardio-metabolic Risk Patients N/A
Completed NCT02678390 - Medium Chain Triglycerides and Aerobic Exercise on Ketone Production in Women With or Without Prediabetes N/A
Completed NCT02459691 - Culturally-adapted Diabetes Prevention Lifestyle Intervention for Latinos (E-LITE Latinos) N/A
Completed NCT01479933 - Glucose Metabolism Effects of Vitamin D Supplementation in Prediabetes N/A
Completed NCT01671293 - Multicomponent Telecare Model for Supporting Prediabetes Patients N/A
Completed NCT00960973 - The Effect of Vitamin K Supplementation on Glucose Metabolism Phase 4
Completed NCT00455325 - Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS) Phase 2
Recruiting NCT05123963 - Restoring 24-hour Substrate Rhythmicity to Improve Glycemic Control by Timing of Lifestyle Factors N/A
Recruiting NCT05340868 - Genetics of the Acute Response to Oral Semaglutide N/A
Recruiting NCT04984421 - IMplementation of the Family Support PRogramme A Healthy School Start to Prevent OVErweight and Obesity (IMPROVE) N/A
Recruiting NCT04131582 - Effect of Empagliflozin + Linagliptin + Metformin + Lifestyle in Patients With Prediabetes Phase 3
Recruiting NCT04134650 - Effect of Low Dose Combination of Linagliptin + Metformin to Prevent Diabetes Phase 3
Recruiting NCT05347030 - Acupuncture for Impaired Glucose Tolerance in Overweight/Obese Population N/A
Completed NCT04074148 - Effectiveness of Diabetes Prevention Education Program on Diabetes Prevention Among Prediabetes Population in Nepal N/A
Recruiting NCT05050266 - Enhancing Mental and Physical Health of Women Veterans N/A
Completed NCT02684565 - Effects of Branch Chain Amino Acids on Glucose Tolerance in Obese Pre-Diabetic Subjects N/A